# US 2026/0096750 A1 · Low Power Implantable Glucose Sensors and Methods of Glucose Measurement

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0096750 A1
- Document ID: US20260096750A1
- Status: Published application
- Kind: A1
- Application number: 19/354,116
- Filed: 2025-10-09
- Published: 2026-04-09
- Earliest claimed: 2024-04-12
- Assignees: Glucotrack, Inc.
- Applicants: Glucotrack, Inc.
- Inventors: Paul V. Goode; Mark Allan Tapsak; James Patrick Thrower; Peter Koziar, JR.
- Web page: https://patentgrep.com/patent/US20260096750A1

## CPC

- A61B 5/14532: {for measuring glucose, e.g. by tissue impedance measurement}
- A61B 5/14735: {comprising an immobilised reagent}
- A61B 5/14865: {invasive, e.g. introduced into the body by a catheter or needle or using implanted sensors}
- A61B 5/6847: {mounted on an invasive device}
- A61B 5/6876: {Blood vessel}
- A61B 5/7225: {Details of analogue processing, e.g. isolation amplifier, gain or sensitivity adjustment, filtering, baseline or drift compensation (input circuits for detecting, measuring, or recording bioelectric or biomagnetic signals A61B5/30; specific diagnostic methods using bioelectric or biomagnetic signals A61B5/316)}
- A61B 2560/0209: adapted for power saving
- A61B 2560/0468: Built-in electrodes
- A61B 2562/227: Sensors with electrical connectors
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)

## Abstract

A device for continuously monitoring glucose levels in a patient includes a lead assembly in electrical communication with an electronics assembly. The electronics assembly is configured to be positioned in the subcutaneous tissue and the lead assembly is configured to be positioned in a vessel of the patient, such as in a vein or in an epidural space. The lead assembly has a lumen, and includes at least one electrode in electrical communication with the electronics assembly.

## Claims

### Claim 1

A glucose sensor adapted to be at least partially positioned within a vessel in a biological host, comprising:
a lead assembly comprising a lead that includes at least one electrode having a surface area of at least 5 mm2, wherein a portion of the lead is configured to be positioned within the vessel, wherein said portion has a length that is less than 15 cm, and wherein the lead assembly is configured to generate a current; and
an electronics assembly connected to an end of the lead assembly, positioned at a distance of at least 5 cm from the at least one electrode, wherein the electronics assembly is in electrical communication with the at least one electrode and adapted to receive the current, wherein the electronics assembly comprises a potentiostat in electrical communication with the lead, and wherein the potentiostat is configured to apply a bias potential to the at least one electrode, to receive the current via the lead, and to convert the current into an analog voltage signal.

### Claim 2 (depends on 1)

The glucose sensor of claim 1, further comprising a digital subassembly configured to receive the analog voltage signal from the potentiostat and process the analog voltage signal by adaptively applying a gain to the analog voltage signal based on the current or changes to the current and generate a gain adjusted signal that is indicative of a glucose level of the biological host.

### Claim 3 (depends on 1)

The glucose sensor of claim 1, wherein a diameter of the lead is in a range from 0.5 mm to 3.0 mm.

### Claim 4 (depends on 1)

The glucose sensor of claim 1, wherein the at least one electrode comprises three electrodes, wherein the first electrode is a working electrode, wherein the second electrode is a reference electrode, and wherein the third electrode is a counter electrode.

### Claim 5 (depends on 1)

The glucose sensor of claim 1, wherein the at least one electrode comprises two electrodes, wherein the first electrode is a working electrode and wherein the second electrode is a combined reference electrode and counter electrode.

### Claim 6 (depends on 1)

The glucose sensor of claim 1, wherein a portion of the lead is coated with an enzyme and wherein said portion ranges from 5 mm to 15 mm in length.

### Claim 7 (depends on 1)

The glucose sensor of claim 1, further comprising an enzyme layer positioned over the surface area of the at least one electrode and a glucose limiting membrane positioned over the enzyme layer, wherein the enzyme layer has a thickness in a range of 3 microns to 60 microns and comprises glucose oxidase, and wherein the glucose limiting membrane has a thickness ranging from 3 microns to 60 microns.

### Claim 8 (depends on 1)

The glucose sensor of claim 1, wherein a cross-sectional area of the sensor is in a range of 0.4% to 10% of a cross-sectional area of the vessel.

### Claim 9 (depends on 1)

The glucose sensor of claim 1, wherein a cross-sectional area of the sensor is in a range of 1% to 3% of a cross-sectional area of the vessel.

### Claim 10 (depends on 1)

The glucose sensor of claim 1, wherein a cross-sectional area of the sensor does not occupy more than 10% of a cross-sectional area of the vessel.

### Claim 11 (depends on 1)

The glucose sensor of claim 1, wherein the electronics assembly is adapted to apply a voltage to the at least one electrode.

### Claim 12 (depends on 1)

The glucose sensor of claim 1, wherein the electronics assembly comprises a digital processing portion separate and distinct from the potentiostat, wherein the digital processing portion further comprises a processor configured to draw power, and wherein a portion of the electronics assembly comprising the potentiostat draws less than 3 microwatts of power above the processing power of the digital processing portion.

### Claim 13 (depends on 1)

The glucose sensor of claim 1, wherein the electronics assembly comprises an analog subassembly, wherein the potentiostat is part of the analog subassembly, and wherein the analog subassembly is adapted to maintain a specified reference voltage constant to within 300 mV of a set point over a time period greater than 30 seconds without requiring any additional power to maintain said specified reference voltage, and wherein the analog subassembly is configured to adjust a reference voltage using signals of varying duration at voltages higher and lower than the specified reference voltage.

### Claim 14 (depends on 13)

The glucose sensor of claim 13, wherein the analog front end circuitry is adapted using a microcontroller to adjust voltage values on a capacitor to converge to the specified reference voltage over more than one iteration of signal adjustments, wherein a digital-to-analog converter is used to create an analog voltage for the capacitor.

### Claim 15 (depends on 1)

The glucose sensor of claim 1, wherein the electronics assembly comprises a processor adapted to program the potentiostat to maintain a constant voltage potential at a pre-programmed value.

### Claim 16 (depends on 15)

The glucose sensor of claim 15, wherein said processor is further adapted to modify said programmed value based on at least one predefined criterion.

### Claim 17

A method of sensing a glucose level of a biological host using a glucose sensor adapted to be at least partially positioned within a vessel in the biological host, comprising:
generating a current using a lead assembly comprising a lead that includes at least one electrode having a surface area of at least 5 mm2, wherein a portion of the lead is configured to be positioned within the vessel, and wherein said portion has a length that is less than 15 centimeters; and
processing the current using an electronics assembly connected to an end of the lead assembly, positioned at a distance of at least 5 cm from the at least one electrode, wherein the electronics assembly is in electrical communication with the at least one electrode and adapted to receive the current, wherein the electronics assembly comprises a potentiostat in electrical communication with the lead, and wherein the potentiostat is configured to apply a bias potential to the at least one electrode, to receive the current via the lead, and to convert the current into an analog voltage signal.

### Claim 18 (depends on 17)

The method of claim 17, further comprising receiving, at a digital subassembly, the analog voltage signal from the potentiostat and processing the analog voltage signal by adaptively applying a gain to the analog voltage signal based on the current or changes to the current and generating a gain adjusted signal that is indicative of a glucose level of the biological host.

### Claim 19 (depends on 17)

The method of claim 17, wherein a diameter of the lead is in a range from 0.5 mm to 3.0 mm.

### Claim 20 (depends on 17)

The method of claim 17, wherein the at least one electrode comprises three electrodes, wherein the first electrode is a working electrode, wherein the second electrode is a reference electrode, and wherein the third electrode is a counter electrode.
